CINGULATE -CW23 (CINGW)

0.0513  -0.01 (-16.18%)

CINGULATE -CW23

NASDAQ:CINGW (12/30/2024, 11:44:26 AM)

0.0513

-0.01 (-16.18%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorN/A
GICS IndustryN/A
GICS SubIndustryN/A
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
CRS80.94
6 Month466.67%
Overview
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Ins OwnersN/A
Inst OwnersN/A
Market Cap0
SharesN/A
PEN/A
Fwd PEN/A
Dividend YieldN/A
AnalystsN/A
Short Float %N/A
Short Ratio0.11
IPON/A N/A
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

CINGW Daily chart

CINGW News

News Image7 days ago - Cingulate Inc.Cingulate Completes Financing Transaction for Net Proceeds of $5,000,000

Cash Runway Extended Beyond Planned NDA Submission of CTx-1301...

News Image2 months ago - Cingulate Inc.Cingulate Reports Third Quarter 2024 Financial Results Reflecting $19.5 Million Increase in Working Capital to Advance ADHD Drug to Market

On Target for Mid-2025 New Drug Application (NDA) Submission of lead ADHD asset CTx-1301...

News Image3 months ago - Cingulate Inc.Cingulate’s Shane Schaffer Joins Cast of Nationally Syndicated Big Biz Show

KANSAS CITY, Kan., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Shane J. Schaffer, Chairman and CEO of Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company...

News Image4 months ago - Cingulate Inc.Cingulate Initiates Final Study for Lead ADHD Asset CTx-1301

$10 Million of additional Capital Recently Raised Strengthening Balance Sheet...

News Image4 months ago - Cingulate Inc.Cingulate to Participate in Benzinga All Live Access Event

KANSAS CITY, Kan., Aug. 27, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed...

News Image4 months ago - Cingulate Inc.Cingulate Announces Adjournment of Special Meeting

KANSAS CITY, Kan., Aug. 23, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ:CING), (“Cingulate” or the “Company”), a biopharmaceutical company utilizing...

CINGW Twits

Here you can normally see the latest stock twits on CINGW, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example